0000950170-24-030331.txt : 20240312 0000950170-24-030331.hdr.sgml : 20240312 20240312202420 ACCESSION NUMBER: 0000950170-24-030331 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240311 FILED AS OF DATE: 20240312 DATE AS OF CHANGE: 20240312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KURIYEL RALF CENTRAL INDEX KEY: 0001733143 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14656 FILM NUMBER: 24744220 MAIL ADDRESS: STREET 1: 41 SEYON ST STREET 2: BLDG 1, STE. 100 CITY: WALTHAM STATE: MA ZIP: 02452 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 ownership.xml 4 X0508 4 2024-03-11 0000730272 REPLIGEN CORP RGEN 0001733143 KURIYEL RALF C/O REPLIGEN CORPORATION 41 SEYON ST., BLDG 1, STE 100 WALTHAM MA 02453 false true false false Senior VP, R&D false Common Stock 2024-03-11 4 M false 1271 86.10 A 27777 D Common Stock 2024-03-11 4 S false 3517 193.73 D 24260 D Stock Option (Right to Buy) 86.10 2024-03-11 4 M false 1271 0.00 A 2030-02-27 Common Stock 1271 0 D $193.73 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.64 to $194.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. This option is fully vested and exercisable. /s/ Kimberly Brown (Attorney in Fact) 2024-03-12